 | • レポートコード：QFJ1-4338 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、遠視治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術治療、レンズ矯正）、用途別市場規模（病院、専門センター、診断センター、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遠視治療の市場動向 ・企業の競争状況、市場シェア ・遠視治療の種類別市場規模と予測2016-2027（手術治療、レンズ矯正） ・遠視治療の用途別市場規模と予測2016-2027（病院、専門センター、診断センター、診療所、その他） ・遠視治療の北米市場規模2016-2027（アメリカ、カナダ） ・遠視治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遠視治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遠視治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・遠視治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan plc、Abbott Laboratories Inc.、ALCON VISION LLC、Bausch + Lomb Incorporated、Carl Zeiss Inc.、Essilor Ltd.、Haag-Streit UK、Johnson & Johnson Vision、Lasersight Technologies Inc.、Nidek Co. Ltd.、ORASIS Pharmaceuticals Ltd.、Topcon Corporation、Visioneering Technologies, Inc.、Ziemer Ophthalmic Systems AG） ・結論 |
Market Analysis and Insights: Global Hypermetropia Treatment Market
The global Hypermetropia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypermetropia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypermetropia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypermetropia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypermetropia Treatment market.
Global Hypermetropia Treatment Scope and Market Size
Hypermetropia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypermetropia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgery Treatment
Lens Correction
Segment by Application
Hospitals
Specialty Centers
Diagnostic Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan plc
Abbott Laboratories Inc.
ALCON VISION LLC
Bausch + Lomb Incorporated
Carl Zeiss Inc.
Essilor Ltd.
Haag-Streit UK
Johnson & Johnson Vision
Lasersight Technologies Inc.
Nidek Co. Ltd.
ORASIS Pharmaceuticals Ltd.
Topcon Corporation
Visioneering Technologies, Inc.
Ziemer Ophthalmic Systems AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypermetropia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery Treatment
1.2.3 Lens Correction
1.3 Market by Application
1.3.1 Global Hypermetropia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Centers
1.3.4 Diagnostic Centers
1.3.5 Clinics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hypermetropia Treatment Market Perspective (2016-2027)
2.2 Hypermetropia Treatment Growth Trends by Regions
2.2.1 Hypermetropia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hypermetropia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hypermetropia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hypermetropia Treatment Industry Dynamic
2.3.1 Hypermetropia Treatment Market Trends
2.3.2 Hypermetropia Treatment Market Drivers
2.3.3 Hypermetropia Treatment Market Challenges
2.3.4 Hypermetropia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypermetropia Treatment Players by Revenue
3.1.1 Global Top Hypermetropia Treatment Players by Revenue (2016-2021)
3.1.2 Global Hypermetropia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hypermetropia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypermetropia Treatment Revenue
3.4 Global Hypermetropia Treatment Market Concentration Ratio
3.4.1 Global Hypermetropia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypermetropia Treatment Revenue in 2020
3.5 Hypermetropia Treatment Key Players Head office and Area Served
3.6 Key Players Hypermetropia Treatment Product Solution and Service
3.7 Date of Enter into Hypermetropia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypermetropia Treatment Breakdown Data by Type
4.1 Global Hypermetropia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hypermetropia Treatment Forecasted Market Size by Type (2022-2027)
5 Hypermetropia Treatment Breakdown Data by Application
5.1 Global Hypermetropia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hypermetropia Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hypermetropia Treatment Market Size (2016-2027)
6.2 North America Hypermetropia Treatment Market Size by Type
6.2.1 North America Hypermetropia Treatment Market Size by Type (2016-2021)
6.2.2 North America Hypermetropia Treatment Market Size by Type (2022-2027)
6.2.3 North America Hypermetropia Treatment Market Size by Type (2016-2027)
6.3 North America Hypermetropia Treatment Market Size by Application
6.3.1 North America Hypermetropia Treatment Market Size by Application (2016-2021)
6.3.2 North America Hypermetropia Treatment Market Size by Application (2022-2027)
6.3.3 North America Hypermetropia Treatment Market Size by Application (2016-2027)
6.4 North America Hypermetropia Treatment Market Size by Country
6.4.1 North America Hypermetropia Treatment Market Size by Country (2016-2021)
6.4.2 North America Hypermetropia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hypermetropia Treatment Market Size (2016-2027)
7.2 Europe Hypermetropia Treatment Market Size by Type
7.2.1 Europe Hypermetropia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hypermetropia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hypermetropia Treatment Market Size by Type (2016-2027)
7.3 Europe Hypermetropia Treatment Market Size by Application
7.3.1 Europe Hypermetropia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hypermetropia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hypermetropia Treatment Market Size by Application (2016-2027)
7.4 Europe Hypermetropia Treatment Market Size by Country
7.4.1 Europe Hypermetropia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hypermetropia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hypermetropia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hypermetropia Treatment Market Size by Type
8.2.1 Asia-Pacific Hypermetropia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hypermetropia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hypermetropia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hypermetropia Treatment Market Size by Application
8.3.1 Asia-Pacific Hypermetropia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hypermetropia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hypermetropia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hypermetropia Treatment Market Size by Region
8.4.1 Asia-Pacific Hypermetropia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hypermetropia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hypermetropia Treatment Market Size (2016-2027)
9.2 Latin America Hypermetropia Treatment Market Size by Type
9.2.1 Latin America Hypermetropia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hypermetropia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hypermetropia Treatment Market Size by Type (2016-2027)
9.3 Latin America Hypermetropia Treatment Market Size by Application
9.3.1 Latin America Hypermetropia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hypermetropia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hypermetropia Treatment Market Size by Application (2016-2027)
9.4 Latin America Hypermetropia Treatment Market Size by Country
9.4.1 Latin America Hypermetropia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hypermetropia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypermetropia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hypermetropia Treatment Market Size by Type
10.2.1 Middle East & Africa Hypermetropia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hypermetropia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hypermetropia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hypermetropia Treatment Market Size by Application
10.3.1 Middle East & Africa Hypermetropia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hypermetropia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hypermetropia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hypermetropia Treatment Market Size by Country
10.4.1 Middle East & Africa Hypermetropia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hypermetropia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Details
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Hypermetropia Treatment Introduction
11.1.4 Allergan plc Revenue in Hypermetropia Treatment Business (2016-2021)
11.1.5 Allergan plc Recent Development
11.2 Abbott Laboratories Inc.
11.2.1 Abbott Laboratories Inc. Company Details
11.2.2 Abbott Laboratories Inc. Business Overview
11.2.3 Abbott Laboratories Inc. Hypermetropia Treatment Introduction
11.2.4 Abbott Laboratories Inc. Revenue in Hypermetropia Treatment Business (2016-2021)
11.2.5 Abbott Laboratories Inc. Recent Development
11.3 ALCON VISION LLC
11.3.1 ALCON VISION LLC Company Details
11.3.2 ALCON VISION LLC Business Overview
11.3.3 ALCON VISION LLC Hypermetropia Treatment Introduction
11.3.4 ALCON VISION LLC Revenue in Hypermetropia Treatment Business (2016-2021)
11.3.5 ALCON VISION LLC Recent Development
11.4 Bausch + Lomb Incorporated
11.4.1 Bausch + Lomb Incorporated Company Details
11.4.2 Bausch + Lomb Incorporated Business Overview
11.4.3 Bausch + Lomb Incorporated Hypermetropia Treatment Introduction
11.4.4 Bausch + Lomb Incorporated Revenue in Hypermetropia Treatment Business (2016-2021)
11.4.5 Bausch + Lomb Incorporated Recent Development
11.5 Carl Zeiss Inc.
11.5.1 Carl Zeiss Inc. Company Details
11.5.2 Carl Zeiss Inc. Business Overview
11.5.3 Carl Zeiss Inc. Hypermetropia Treatment Introduction
11.5.4 Carl Zeiss Inc. Revenue in Hypermetropia Treatment Business (2016-2021)
11.5.5 Carl Zeiss Inc. Recent Development
11.6 Essilor Ltd.
11.6.1 Essilor Ltd. Company Details
11.6.2 Essilor Ltd. Business Overview
11.6.3 Essilor Ltd. Hypermetropia Treatment Introduction
11.6.4 Essilor Ltd. Revenue in Hypermetropia Treatment Business (2016-2021)
11.6.5 Essilor Ltd. Recent Development
11.7 Haag-Streit UK
11.7.1 Haag-Streit UK Company Details
11.7.2 Haag-Streit UK Business Overview
11.7.3 Haag-Streit UK Hypermetropia Treatment Introduction
11.7.4 Haag-Streit UK Revenue in Hypermetropia Treatment Business (2016-2021)
11.7.5 Haag-Streit UK Recent Development
11.8 Johnson & Johnson Vision
11.8.1 Johnson & Johnson Vision Company Details
11.8.2 Johnson & Johnson Vision Business Overview
11.8.3 Johnson & Johnson Vision Hypermetropia Treatment Introduction
11.8.4 Johnson & Johnson Vision Revenue in Hypermetropia Treatment Business (2016-2021)
11.8.5 Johnson & Johnson Vision Recent Development
11.9 Lasersight Technologies Inc.
11.9.1 Lasersight Technologies Inc. Company Details
11.9.2 Lasersight Technologies Inc. Business Overview
11.9.3 Lasersight Technologies Inc. Hypermetropia Treatment Introduction
11.9.4 Lasersight Technologies Inc. Revenue in Hypermetropia Treatment Business (2016-2021)
11.9.5 Lasersight Technologies Inc. Recent Development
11.10 Nidek Co. Ltd.
11.10.1 Nidek Co. Ltd. Company Details
11.10.2 Nidek Co. Ltd. Business Overview
11.10.3 Nidek Co. Ltd. Hypermetropia Treatment Introduction
11.10.4 Nidek Co. Ltd. Revenue in Hypermetropia Treatment Business (2016-2021)
11.10.5 Nidek Co. Ltd. Recent Development
11.11 ORASIS Pharmaceuticals Ltd.
11.11.1 ORASIS Pharmaceuticals Ltd. Company Details
11.11.2 ORASIS Pharmaceuticals Ltd. Business Overview
11.11.3 ORASIS Pharmaceuticals Ltd. Hypermetropia Treatment Introduction
11.11.4 ORASIS Pharmaceuticals Ltd. Revenue in Hypermetropia Treatment Business (2016-2021)
11.11.5 ORASIS Pharmaceuticals Ltd. Recent Development
11.12 Topcon Corporation
11.12.1 Topcon Corporation Company Details
11.12.2 Topcon Corporation Business Overview
11.12.3 Topcon Corporation Hypermetropia Treatment Introduction
11.12.4 Topcon Corporation Revenue in Hypermetropia Treatment Business (2016-2021)
11.12.5 Topcon Corporation Recent Development
11.13 Visioneering Technologies, Inc.
11.13.1 Visioneering Technologies, Inc. Company Details
11.13.2 Visioneering Technologies, Inc. Business Overview
11.13.3 Visioneering Technologies, Inc. Hypermetropia Treatment Introduction
11.13.4 Visioneering Technologies, Inc. Revenue in Hypermetropia Treatment Business (2016-2021)
11.13.5 Visioneering Technologies, Inc. Recent Development
11.14 Ziemer Ophthalmic Systems AG
11.14.1 Ziemer Ophthalmic Systems AG Company Details
11.14.2 Ziemer Ophthalmic Systems AG Business Overview
11.14.3 Ziemer Ophthalmic Systems AG Hypermetropia Treatment Introduction
11.14.4 Ziemer Ophthalmic Systems AG Revenue in Hypermetropia Treatment Business (2016-2021)
11.14.5 Ziemer Ophthalmic Systems AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hypermetropia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery Treatment
Table 3. Key Players of Lens Correction
Table 4. Global Hypermetropia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hypermetropia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hypermetropia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hypermetropia Treatment Market Share by Regions (2016-2021)
Table 8. Global Hypermetropia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hypermetropia Treatment Market Share by Regions (2022-2027)
Table 10. Hypermetropia Treatment Market Trends
Table 11. Hypermetropia Treatment Market Drivers
Table 12. Hypermetropia Treatment Market Challenges
Table 13. Hypermetropia Treatment Market Restraints
Table 14. Global Hypermetropia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hypermetropia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Hypermetropia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypermetropia Treatment as of 2020)
Table 17. Ranking of Global Top Hypermetropia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hypermetropia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hypermetropia Treatment Product Solution and Service
Table 21. Date of Enter into Hypermetropia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hypermetropia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hypermetropia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Hypermetropia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hypermetropia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hypermetropia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hypermetropia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Hypermetropia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hypermetropia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hypermetropia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hypermetropia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hypermetropia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hypermetropia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hypermetropia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hypermetropia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hypermetropia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hypermetropia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hypermetropia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hypermetropia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hypermetropia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hypermetropia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hypermetropia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hypermetropia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hypermetropia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hypermetropia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hypermetropia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hypermetropia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hypermetropia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hypermetropia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hypermetropia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hypermetropia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hypermetropia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hypermetropia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hypermetropia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hypermetropia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hypermetropia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hypermetropia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hypermetropia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hypermetropia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Allergan plc Company Details
Table 62. Allergan plc Business Overview
Table 63. Allergan plc Hypermetropia Treatment Product
Table 64. Allergan plc Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 65. Allergan plc Recent Development
Table 66. Abbott Laboratories Inc. Company Details
Table 67. Abbott Laboratories Inc. Business Overview
Table 68. Abbott Laboratories Inc. Hypermetropia Treatment Product
Table 69. Abbott Laboratories Inc. Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 70. Abbott Laboratories Inc. Recent Development
Table 71. ALCON VISION LLC Company Details
Table 72. ALCON VISION LLC Business Overview
Table 73. ALCON VISION LLC Hypermetropia Treatment Product
Table 74. ALCON VISION LLC Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 75. ALCON VISION LLC Recent Development
Table 76. Bausch + Lomb Incorporated Company Details
Table 77. Bausch + Lomb Incorporated Business Overview
Table 78. Bausch + Lomb Incorporated Hypermetropia Treatment Product
Table 79. Bausch + Lomb Incorporated Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 80. Bausch + Lomb Incorporated Recent Development
Table 81. Carl Zeiss Inc. Company Details
Table 82. Carl Zeiss Inc. Business Overview
Table 83. Carl Zeiss Inc. Hypermetropia Treatment Product
Table 84. Carl Zeiss Inc. Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 85. Carl Zeiss Inc. Recent Development
Table 86. Essilor Ltd. Company Details
Table 87. Essilor Ltd. Business Overview
Table 88. Essilor Ltd. Hypermetropia Treatment Product
Table 89. Essilor Ltd. Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 90. Essilor Ltd. Recent Development
Table 91. Haag-Streit UK Company Details
Table 92. Haag-Streit UK Business Overview
Table 93. Haag-Streit UK Hypermetropia Treatment Product
Table 94. Haag-Streit UK Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 95. Haag-Streit UK Recent Development
Table 96. Johnson & Johnson Vision Company Details
Table 97. Johnson & Johnson Vision Business Overview
Table 98. Johnson & Johnson Vision Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 99. Johnson & Johnson Vision Recent Development
Table 100. Lasersight Technologies Inc. Company Details
Table 101. Lasersight Technologies Inc. Business Overview
Table 102. Lasersight Technologies Inc. Hypermetropia Treatment Product
Table 103. Lasersight Technologies Inc. Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 104. Lasersight Technologies Inc. Recent Development
Table 105. Nidek Co. Ltd. Company Details
Table 106. Nidek Co. Ltd. Business Overview
Table 107. Nidek Co. Ltd. Hypermetropia Treatment Product
Table 108. Nidek Co. Ltd. Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 109. Nidek Co. Ltd. Recent Development
Table 110. ORASIS Pharmaceuticals Ltd. Company Details
Table 111. ORASIS Pharmaceuticals Ltd. Business Overview
Table 112. ORASIS Pharmaceuticals Ltd. Hypermetropia Treatment Product
Table 113. ORASIS Pharmaceuticals Ltd. Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 114. ORASIS Pharmaceuticals Ltd. Recent Development
Table 115. Topcon Corporation Company Details
Table 116. Topcon Corporation Business Overview
Table 117. Topcon Corporation Hypermetropia Treatment Product
Table 118. Topcon Corporation Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 119. Topcon Corporation Recent Development
Table 120. Visioneering Technologies, Inc. Company Details
Table 121. Visioneering Technologies, Inc. Business Overview
Table 122. Visioneering Technologies, Inc. Hypermetropia Treatment Product
Table 123. Visioneering Technologies, Inc. Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 124. Visioneering Technologies, Inc. Recent Development
Table 125. Ziemer Ophthalmic Systems AG Company Details
Table 126. Ziemer Ophthalmic Systems AG Business Overview
Table 127. Ziemer Ophthalmic Systems AG Hypermetropia Treatment Product
Table 128. Ziemer Ophthalmic Systems AG Revenue in Hypermetropia Treatment Business (2016-2021) & (US$ Million)
Table 129. Ziemer Ophthalmic Systems AG Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypermetropia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Treatment Features
Figure 3. Lens Correction Features
Figure 4. Global Hypermetropia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Hypermetropia Treatment Report Years Considered
Figure 11. Global Hypermetropia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Hypermetropia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hypermetropia Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Hypermetropia Treatment Market Share by Regions (2022-2027)
Figure 15. Global Hypermetropia Treatment Market Share by Players in 2020
Figure 16. Global Top Hypermetropia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypermetropia Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Hypermetropia Treatment Revenue in 2020
Figure 18. Global Hypermetropia Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Hypermetropia Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Hypermetropia Treatment Market Share by Type (2016-2027)
Figure 22. North America Hypermetropia Treatment Market Share by Application (2016-2027)
Figure 23. North America Hypermetropia Treatment Market Share by Country (2016-2027)
Figure 24. United States Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hypermetropia Treatment Market Share by Type (2016-2027)
Figure 28. Europe Hypermetropia Treatment Market Share by Application (2016-2027)
Figure 29. Europe Hypermetropia Treatment Market Share by Country (2016-2027)
Figure 30. Germany Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hypermetropia Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Hypermetropia Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Hypermetropia Treatment Market Share by Region (2016-2027)
Figure 40. China Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hypermetropia Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Hypermetropia Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Hypermetropia Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hypermetropia Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Hypermetropia Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Hypermetropia Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Hypermetropia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan plc Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 60. Abbott Laboratories Inc. Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 61. ALCON VISION LLC Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 62. Bausch + Lomb Incorporated Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 63. Carl Zeiss Inc. Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 64. Essilor Ltd. Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 65. Haag-Streit UK Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 66. Johnson & Johnson Vision Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 67. Lasersight Technologies Inc. Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 68. Nidek Co. Ltd. Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 69. ORASIS Pharmaceuticals Ltd. Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 70. Topcon Corporation Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 71. Visioneering Technologies, Inc. Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 72. Ziemer Ophthalmic Systems AG Revenue Growth Rate in Hypermetropia Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の乳房乳腺腫瘤摘出術治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Lumpectomy Treatment Market The global Breast Lumpectomy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…- 世界のスポロトリクスシェンキー感染症治療市場規模・現状・予測（2021年-2027年） Skin-related issues are one of the frequently occurring issues worldwide. One such issue is Sporotrichosis. Sporotrichosis is caused by a dimorphic fungus, called Sporothrix Schenckii, and is commonly called gardeners' disease due to number of people affected when carrying out cultivation in farms a…
- 世界のハースル細胞がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hurthle Cell Carcinoma Treatment Market The global Hurthle Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の非薬物式うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Free Depression Treatment Market The global Drug Free Depression Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
- 世界の色汗症治療市場規模・現状・予測（2021年-2027年） Chromhidrosis is a rare condition characterized by the secretion of colored sweat. There are two types of glands such as apocrine and eccrine gland. Apocrine glands secrete a milky sweat that, once fragmented down by bacteria, is the main cause of body odor whereas Eccrine glands secrete an odorless…